Trial
NCT01774487
Pentoxifylline Therapy in Biliary Atresia
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Baylor College of Medicine
Collaborators
—
Condition
Biliary Atresia
Intervention
Pentoxifylline
Why stopped
Target enrollment was not reached because the medication, pentoxifylline, has a taste that is not well tolerated by infants. The study team decided to end the study before meeting the enrollment goal because of the medication taste.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-11